Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/0e/d3/61/0ed36162-1a10-593c-23d0-d845b8f60dde/mza_4285820417265132393.png/600x600bb.jpg
Medscape InDiscussion: Renal Cell Carcinoma
Medscape
12 episodes
2 weeks ago
Listen to Medscape InDiscussion: Renal Cell Carcinoma, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984237). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Show more...
Science
Health & Fitness,
Medicine
RSS
All content for Medscape InDiscussion: Renal Cell Carcinoma is the property of Medscape and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Listen to Medscape InDiscussion: Renal Cell Carcinoma, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984237). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Show more...
Science
Health & Fitness,
Medicine
Episodes (12/12)
Medscape InDiscussion: Renal Cell Carcinoma
S2 Episode 6: What's New in the Field of Neoadjuvant Therapy and Renal Cell Carcinoma?
2 years ago
20 minutes 57 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S2 Episode 5: The Epidemiology of Renal Cell Carcinoma: Risk Factors, Cystic Disease, the Microbiome, and the Mycobiome
2 years ago
20 minutes 25 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S2 Episode 4: What Can Patient-centered Quality-of-Life Research in Bladder Cancer Teach Us About Kidney Cancer?
2 years ago
22 minutes 35 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S2 Episode 3: Renal Medullary Carcinoma: The Importance of Early and Accurate Screening, Diagnosis, and Treatment
2 years ago
23 minutes 7 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S2 Episode 2: How Single-Cell Sequencing Can Help in Renal Cell Carcinoma
2 years ago
21 minutes 36 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S2 Episode 1: Tissue Biomarkers in Renal Cell Carcinoma: Are We Ready for Prime Time?
2 years ago
22 minutes 42 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S1 Episode 6: Second-Line Treatment of Renal Cell Carcinoma
2 years ago
20 minutes 41 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S1 Episode 5: Biomarkers and Renal Cell Carcinoma
2 years ago
22 minutes 51 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S1 Episode 4: How Does the Gut Microbiome Impact Response to Cancer Therapy?
3 years ago
22 minutes 16 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S1 Episode 3: Non–Clear Cell Renal Cell Carcinoma: A Conversation About Subtypes, Clinical Trials, Treatment Options, and Outcomes
3 years ago
20 minutes 40 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S1 Episode 2: Adjuvant Treatment With Immunotherapy
3 years ago
22 minutes 37 seconds

Medscape InDiscussion: Renal Cell Carcinoma
S1 Episode 1: Frontline Treatment of Renal Cell Carcinoma
3 years ago
20 minutes 44 seconds

Medscape InDiscussion: Renal Cell Carcinoma
Listen to Medscape InDiscussion: Renal Cell Carcinoma, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984237). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.